Clarity and risk: the challenges of the new technologies.
作者信息
Williams D
机构信息
Department of Clinical Engineering, University of Liverpool.
出版信息
Med Device Technol. 2001 Nov;12(9):12-4.
PMID:12938531
Abstract
Tissue engineering, xenotransplantation, gene and cell therapy and other emerging products and processes are altering the way in which risks can be assessed and are bringing new challenges to product demarcation.
摘要
相似文献
1
Clarity and risk: the challenges of the new technologies.
Med Device Technol. 2001 Nov;12(9):12-4.
2
Does standardisation have a role in nanotechnology and medicine?
Med Device Technol. 2004 Mar;15(2):28.
3
Innovation and patents: in vitro diagnostics.
Med Device Technol. 2003 May;14(4):24.
4
European legislation of biomedical technology.
Ann Ist Super Sanita. 1995;31(1):109-12.
5
Germany health-care systems at the turning point.
Med Device Technol. 2001 Oct;12(8):35-6.
6
Medical products: growth rate recovery in 1982.
Med Prod Sales. 1982 Feb;13(2):15-6, 56-8, 60.
7
Thermoplastic elastomers in medical applications.
Med Device Technol. 2003 May;14(4):38-40.
8
[Role of the All-Union Medical Technology Society in the creation and manufacture of medical equipment].
Med Tekh. 1978 Nov-Dec(6):9-11.
9
[Prospects of the use of new technology for producing precision instruments from glass].
Med Tekh. 1989 Sep-Oct(5):32-4.
10
Not long to go: the end of the transition period approaches.
Med Device Technol. 1997 Nov;8(9):28-30.
引用本文的文献
1
Recent developments in gene transfer: risk and ethics.
BMJ. 2005 Jan 8;330(7482):79-82. doi: 10.1136/bmj.330.7482.79.
2
Human tissue engineered products--drugs or devices?
BMJ. 2003 May 31;326(7400):1159-60. doi: 10.1136/bmj.326.7400.1159.
Zotero 插件